[HTML][HTML] The CXCL8-CXCR1/2 pathways in cancer

Q Liu, A Li, Y Tian, JD Wu, Y Liu, T Li, Y Chen… - Cytokine & growth factor …, 2016 - Elsevier
Persistent infection or chronic inflammation contributes significantly to tumourigenesis and
tumour progression. CXC motif ligand 8 (CXCL8) is a chemokine that acts as an important …

[HTML][HTML] Synergistic effect of immune checkpoint blockade and anti-angiogenesis in cancer treatment

M Yi, D Jiao, S Qin, Q Chu, K Wu, A Li - Molecular cancer, 2019 - Springer
Immune checkpoint inhibitor (ICI) activates host’s anti-tumor immune response by blocking
negative regulatory immune signals. A series of clinical trials showed that ICI could effectively …

[HTML][HTML] Chimeric antigen receptor T cells: a novel therapy for solid tumors

S Yu, A Li, Q Liu, T Li, X Yuan, X Han, K Wu - Journal of hematology & …, 2017 - Springer
The chimeric antigen receptor T (CAR-T) cell therapy is a newly developed adoptive antitumor
treatment. Theoretically, CAR-T cells can specifically localize and eliminate tumor cells by …

The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis

…, C Le Sage, R Nagel, S Nair, DA Egan, A Li… - Nature cell …, 2008 - nature.com
MicroRNAs (miRNAs) are single-stranded, noncoding RNAs that are important in many
biological processes 1 , 2 . Although the oncogenic and tumour-suppressive functions of several …

Evaluation of antioxidant and antibacterial activities of Ficus microcarpa L. fil. extract

C Ao, A Li, AA Elzaawely, TD Xuan, S Tawata - Food control, 2008 - Elsevier
Antioxidant and antibacterial activities were evaluated by the extracts of Ficus microcarpa,
which is one of the traditional medicinal plant and food additives in Okinawa, Japan. Results …

[HTML][HTML] Recent advances on anti-angiogenesis receptor tyrosine kinase inhibitors in cancer therapy

S Qin, A Li, M Yi, S Yu, M Zhang, K Wu - Journal of hematology & oncology, 2019 - Springer
Angiogenesis has always been the topic of major scientific interest in the field of malignant
tumors. Nowadays, targeting angiogenesis has achieved success in various carcinomas by …

[HTML][HTML] Activating cGAS-STING pathway for the optimal effect of cancer immunotherapy

A Li, M Yi, S Qin, Y Song, Q Chu, K Wu - Journal of hematology & oncology, 2019 - Springer
During tumor progression, a subset of cancer cells escape from immune surveillance and
eventually develop into measurable tumor mass. Cancer immunotherapy eradicates tumor …

[HTML][HTML] The global burden and attributable risk factor analysis of acute myeloid leukemia in 195 countries and territories from 1990 to 2017: estimates based on the …

M Yi, A Li, L Zhou, Q Chu, Y Song, K Wu - Journal of hematology & …, 2020 - Springer
Background Acute myeloid leukemia (AML) is a common leukemia subtype and has a poor
prognosis. The risk of AML is highly related to age. In the context of population aging, a …

[HTML][HTML] The role of cancer-derived microRNAs in cancer immune escape

M Yi, L Xu, Y Jiao, S Luo, A Li, K Wu - Journal of hematology & oncology, 2020 - Springer
During malignant transformation, accumulated somatic mutations endow cancer cells with
increased invasiveness and immunogenicity. Under selective pressure, these highly …

Pseudogene PTENP1 functions as a competing endogenous RNA to suppress clear-cell renal cell carcinoma progression

…, A Li, J Wang, W Xiao, K Chen, H Xiao, H Li… - Molecular cancer …, 2014 - AACR
PTENP1 is a pseudogene of the PTEN tumor suppression gene (TSG). The functions of
PTENP1 in clear-cell renal cell carcinoma (ccRCC) have not yet been studied. We found that …